InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: None

Saturday, 02/21/2015 11:47:52 AM

Saturday, February 21, 2015 11:47:52 AM

Post# of 80868
I believe this is built into the stock price:

1) Q4 disappointing in terms of revenue and earnings

2) Q1 not going to be too great, but somewhat better than Q4.

3) minimal dilution expectation going forward

4) Tiger Woods a transaction that will never make money for MSLP

So, in order for the price to go up short term, any of these assumptions need to change for the better. Any further dilution will kill the stock for good and make it a no go stock for institutional investors.

I believe we need to wait for guidance for Q2 for any real upside though as Musclepharm is adjusting to the Walmart and Sam's Club deal. Yearly guidance numbers are not trusted as he will miss Q4.